Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S W Zimmerman

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Archives of Internal Medicine|September 1, 1975
Immunoglobulin A nephropathyS W Zimmerman, P M Burkholder
European Journal of Applied Physiology and Occupational Physiology|May 30, 1978
Human leukocyte response to an endurance raceA V Moorthy, S W Zimmerman
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1989
Intraperitoneal Vancoled does not cause chemical peritonitisC A Johnson, S W Zimmerman
Nephron|January 1, 1974
Heparin therapy for the renal disease of malignant hypertensionS W Zimmerman, J J Bergin
The New England Journal of Medicine|January 11, 1979
Heatstroke in road racesP G Hanson, S W Zimmerman
JAMA|July 13, 1979
Exertional heatstroke in novice runnersP G Hanson, S W Zimmerman
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1989
Rifampin use in peritoneal dialysisS W Zimmerman, C A Johnson
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1991
Erythropoietin use in peritoneal dialysis patientsS W Zimmerman, C A Johnson
Clinical Nephrology|November 1, 1980
Renal disease in the elderly: clinicopathologic analysis of renal disease in 115 elderly patientsA V Moorthy, S W Zimmerman
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
A prospective open-label study evaluating the efficacy and adverse reactions of the use of Niferex-150 in ESRD patients receiving EPOGENC A Johnson, E Rosowski, S W Zimmerman
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Archives of Internal Medicine|September 1, 1975
Immunoglobulin A nephropathyS W Zimmerman, P M Burkholder
European Journal of Applied Physiology and Occupational Physiology|May 30, 1978
Human leukocyte response to an endurance raceA V Moorthy, S W Zimmerman
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1989
Intraperitoneal Vancoled does not cause chemical peritonitisC A Johnson, S W Zimmerman
Nephron|January 1, 1974
Heparin therapy for the renal disease of malignant hypertensionS W Zimmerman, J J Bergin
The New England Journal of Medicine|January 11, 1979
Heatstroke in road racesP G Hanson, S W Zimmerman
JAMA|July 13, 1979
Exertional heatstroke in novice runnersP G Hanson, S W Zimmerman
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1989
Rifampin use in peritoneal dialysisS W Zimmerman, C A Johnson
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1991
Erythropoietin use in peritoneal dialysis patientsS W Zimmerman, C A Johnson
Clinical Nephrology|November 1, 1980
Renal disease in the elderly: clinicopathologic analysis of renal disease in 115 elderly patientsA V Moorthy, S W Zimmerman
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
A prospective open-label study evaluating the efficacy and adverse reactions of the use of Niferex-150 in ESRD patients receiving EPOGENC A Johnson, E Rosowski, S W Zimmerman
Pageof 8